OpGen to Present Antibiotic Resistance Prediction

GAITHERSBURG, Md., April 12, 2017 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) today announced that five posters featuring its technologies will be presented at the 25 ^th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held April 22-25, 2017 in Vienna, Austria. Among them will be a poster presentation titled “Prediction of antibiotic resistance in Escherichia Coli from resistance genes” by Dr. Terry Walker, Senior Vice President of Research and Development at OpGen. The presentation will highlight preliminary results supporting OpGen’s efforts to develop and commercialize a rapid and highly accurate test that predicts antibiotic resistance using resistance gene detection and the bioinformatics capabilities of the Acuitas Lighthouse® Knowledgebase. The OpGen booth location is 32B.

The details for the presentations at ECCMID are as follows:

Poster title:  Prediction of antibiotic resistance in Escherichia coli from resistance genes Presenter: T. Walker, OpGen Date and time:  Tuesday, April 25 from 12:54 - 12:59 pm CEST Location:  Poster Area Poster number: #EP0938 Abstract number: #4182 Session info:  Direct detection methods

Poster title:  Use of the Acuitas Resistome Test to detect and type carbapenemase producing organisms (CPOs): A pilot study Presenter:   G. Vanstone, Royal Free London NHS Foundation Trust Date and time:  Saturday, April 22 from 3:30 - 4:30 pm CEST Location:  Poster Area Poster number:  #P0387 Abstract number: #6205 Session info:  Detection of resistant pathogens

Poster title:  Rapid outbreak detection of multi-drug resistant organisms using resistance genes profiles Presenter: W. Chang, OpGen Date and time:  Saturday, April 22 from 8:45 am - 3:30 pm CEST Location:  Poster Area Poster number: #EV0483 Abstract number: #5396 Session info:  Resistance surveillance & epidemiology: Gram-negatives

Poster title:  Evaluation of QuickFISH and the Sepsityper assays for early identification of aetiological agents in bloodstream infection in a clinical routine setting Presenter: A. Pernestig, Systems Biology Research Centre, University of Skövde Date and time:  Monday, April 24 from 1:30 - 2:30 pm CEST Location:  Poster Area Poster number: #P1561 Abstract number: #1166 Session info:  Diagnostic microbiology

Poster title:  Seven years of clinical experience with the Yeast Traffic Light PNA FISH: assay performance and implications on antifungal therapy Presenter: V. Özenci, Karolinska University Hospital Date and time:  Sunday, April 23 from 1:30 - 2:30 pm CEST Location:  Poster Area Poster number: #P0969 Abstract number: #5533 Session info:  Diagnostic mycology I

About OpGen OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. Learn more at  www.opgen.com  and follow OpGen on Twitter and LinkedIn.

OpGen Contact: Michael Farmer Director, Marketing 240-813-1284 mfarmer@opgen.com InvestorRelations@opgen.com OpGen Investor and Media Contact: MacDougall Biomedical Communications Cammy Duong 781-591-3443 cduong@macbiocom.com